Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada. - Archive ouverte HAL Access content directly
Journal Articles BMC Public Health Year : 2015

Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.

(1) , (1) , (2, 3) , (4) , (3) , (1, 5)
1
2
3
4
5

Abstract

The role of metabolic syndrome (MetS) in prostate cancer risk is still debated. We investigated it in a large population-based case-control study. Cases were 1937 men with incident prostate cancer, aged ≤ 75 years, diagnosed across French hospitals in the Montreal area between 2005 and 2009. Concurrently, 1995 population controls from the same residential area and age distribution were randomly selected from electoral list of French-speaking men. Detailed lifestyle and medical histories, and anthropometric measures, were collected during in-person interviews. Prevalence of MetS components (type 2 diabetes, high blood pressure, dyslipidemia and abdominal obesity) was estimated at 2 years before diagnosis for cases/ interview for controls, and at ages 20, 40, 50 and 60. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals for the association between MetS and prostate cancer risk. A history of MetS (≥ 3 components vs < 3) was associated with a reduced risk of prostate cancer (OR = 0.70 [0.60, 0.82]) after considering potential confounders. The negative association was particularly pronounced with a young age (≤ 40 years) at MetS onset (OR = 0.38 [0.16-0.89]), did not vary according to prostate cancer aggressiveness, and was only partly explained by the presence of type 2 diabetes. A risk decrease was observed with the number of MetS components, suggesting a synergistic interaction of the components. The observed negative association, consistent with results from other North American populations undergoing regular prostate cancer screening, underlines the importance of considering PSA-testing when studying the MetS-prostate cancer association. Findings from this study are consistent with an inverse association between MetS and prostate cancer risk.
Fichier principal
Vignette du fichier
art%3A10.1186%2Fs12889-015-2260-x.pdf (546.94 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-01351901 , version 1 (04-08-2016)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Audrey Blanc-Lapierre, Andrea Spence, Pierre I Karakiewicz, Armen Aprikian, Fred Saad, et al.. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.. BMC Public Health, 2015, 15, pp.913. ⟨10.1186/s12889-015-2260-x⟩. ⟨pasteur-01351901⟩

Collections

RIIP INRS-IAF
58 View
97 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More